This nanovaccine elicited eightfold more frequent neoantigen‐specific peripheral CD8+ T cells than CpG alone, and induced significant tumor regression.115 Researchers also exploited curdlan and mannan for their DC activation ability. The gene discussed is CD8A; the disease is neoplasm.